Assistance Listing 93.396
Cancer Biology Research
Funding history
Awards made under this listing across FY2025–FY2027, from public federal spending records.
- FY2025 obligated
- $914.3M
- FY2026 obligated
- $911.3M
- FY2027 (to date) obligated
- $0
- Awards in window
- 2,957
Top recipients: The Trustees of Columbia University in the City of New York, Sloan-kettering Institute for Cancer Research, The Univeristy of Texas M.d. Anderson Cancer Center, Icahn School of Medicine at Mount Sinai, Trustees of the University of Pennsylvania, the
Source: USAspending.gov · refreshed October 2026
Open opportunities under this listing
- Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
- Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)
- Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)
- New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)
- New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional)
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
- Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
- NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
- NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed)
- NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required)
- Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)
- Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional)
- Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional)
- Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)
- Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
- Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)
- Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)
- Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 eSubmission Clinical Trial Optional)
- The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed)
- Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
- NIH Research Program Projects (Parent P01 Clinical Trial Optional)
- Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) (P30 Clinical Trial Not Allowed)
- Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)
Forecasted
- Investigator-Focused Award (Parent R35)
- Advanced Development and Sustainment of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
- NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)
- NCI Research Specialist Award for Core and Laboratory-based Scientists (R50 Clinical Trial Not Allowed)
- Single Source: Coordinating Center (CC) for the Small Cell Lung Cancer (SCLC) Consortium (U24 Clinical Trial Not Allowed)
Recently closed
- Metastasis Research Network (U54 Clinical Trial Not Allowed)
- Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)
- Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)
- Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)
- Mechanistic links between diet, lipid metabolism, and tumor growth and progression (U01 Clinical Trial Not Allowed)
- Mechanistic links between diet, lipid metabolism, and tumor growth and progression (UH2 Clinical Trial Not Allowed)
- NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)
- NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)
- HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K01 - Clinical Trial Required)
- NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)
- Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
- NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
- Biology of Bladder Cancer (R01 Clinical Trial Optional)
- Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed)
- Centers for AIDS Research (P30 Clinical Trial Not Allowed)
- The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed)
- Development of Animal Models and Related Biological Materials for Down Syndrome Research (R24 Clinical Trials Not-Allowed)
- Building Sustainable Software Tools for Open Science (R03 Clinical Trial Not Allowed)
- HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional)
- Interventions for Stigma Reduction to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle- Income Countries (R01 - Clinical Trial Optional)
- Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)
- Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed)
- Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional)
- Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R21 Clinical Trial Not Allowed)
- Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R01 Clinical Trial Not Allowed)
- HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)
- Impacts of climate change across the cancer control continuum (R21 Clinical Trial Optional)
- Impacts of climate change across the cancer control continuum (R01 Clinical Trial Optional)
- Informatics Tools for the Pangenome (U01 Clinical Trial Not Allowed)
- Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional)
- Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional)
- Limited Competition: AIDS Malignancy Consortium (AMC; UM1 Clinical Trial Required)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)
- Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)
- Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)
- Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R21 Clinical Trial Not Allowed)
- Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R01 Clinical Trial Not Allowed)
- NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
- NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
- Biology of Bladder Cancer (R01 Clinical Trial Optional)
Get grants like this every Tuesday — free
One email a week: the biggest new federal grants and what’s closing soon — the same list for everyone. Unsubscribe any time.
No spam, ever. Privacy
Same-day alerts, matched to you
The free digest is weekly — the same list for everyone. Members get every open federal grant scored to their organization — and an alert the day a real match posts: we read every new posting the day it opens. Free for 30 days, then $29/mo. Card required, cancel any time before day 31.
Not ready for a subscription? A one-time Fit Report — $29 — scores every open federal grant to your organization once, by email within one business day.
See pricing